Abstract
BackgroundThe emergence of biological DMARDs have been a major change for the treatment of Rheumatoid Arthritis (RA) patients. The RA therapeutic algorithm includes: synthetic DMARD monotherapy, synthetic DMARD combination and...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
